Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sucampo Pharma Inc (SCMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 481,793
  • Shares Outstanding, K 46,550
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • 36-Month Beta 1.42
  • Price/Sales 2.02
  • Price/Cash Flow 4.15
  • Price/Book 17.67

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.95 +3.97%
on 10/17/17
12.30 -15.85%
on 09/18/17
-1.80 (-14.81%)
since 09/15/17
3-Month
9.90 +4.55%
on 08/18/17
13.15 -21.29%
on 09/11/17
-0.65 (-5.91%)
since 07/17/17
52-Week
9.30 +11.29%
on 04/18/17
17.55 -41.03%
on 11/30/16
-2.19 (-17.46%)
since 10/17/16

Most Recent Stories

More News
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology

Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside chat at the 2017 Leerink Partners Roundtable Series: Rare...

SCMP : 10.35 (+3.50%)
Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the appointment of Alex Driggs to General Counsel and Corporate Secretary. Mr. Driggs joined Sucampo...

SCMP : 10.35 (+3.50%)
AMGN : 186.19 (+2.36%)
Global Constipation Market Report: Industry Analysis & Outlook 2017-2021 - Research and Markets

The "Global Constipation Market: Industry Analysis & Outlook (2017-2021)" report has been added to Research and Markets' offering.

IRWD : 15.40 (-0.45%)
SCMP : 10.35 (+3.50%)
SGYP : 3.03 (-0.33%)
Cancer Prevention Pharmaceuticals Receives $9.5 Million in Additional Funding from Sucampo Following Phase 3 Trial Progress

Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced it has received a total of $9.5 million...

CPP : N/A (unch)
SCMP : 10.35 (+3.50%)
Sucampo (SCMP) Up 17.1% Since Earnings Report: Can It Continue?

Sucampo (SCMP) reported earnings more than a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

SCMP : 10.35 (+3.50%)
Constipation Treatment Market to Reach US$22.93 Billion by 2025: Escalating Geriatric Population Driving Demand, Says TMR

A freshly-compiled intelligence study by Transparency Market Research (TMR) has noted that a vast number of players are participating in the global constipation treatment market, which has been a prevalent...

VRX.TO : 16.04 (-0.93%)
BAYRY : 35.0600 (-0.65%)
IRWD : 15.40 (-0.45%)
SCMP : 10.35 (+3.50%)
PBH : 47.43 (-0.98%)
SGYP : 3.03 (-0.33%)
SGIOF : 54.3000 (-1.72%)
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Wells Fargo Healthcare Conference

Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 2017 Wells Fargo Healthcare Conference...

WFC : 53.19 (-1.13%)
SCMP : 10.35 (+3.50%)
Sucampo Pha-Cl A Has Returned 18.5% Since SmarTrend Recommendation (SCMP)

SmarTrend identified a Downtrend for Sucampo Pha-Cl A (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 8 months, Sucampo Pha-Cl A has returned 18.53% as of today's recent price of $11.30....

SCMP : 10.35 (+3.50%)
Sucampo Pha-Cl A has the Best Relative Performance in the Pharmaceuticals Industry (SCMP, AKRX, SUPN, ZTS, MRK)

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

SCMP : 10.35 (+3.50%)
SUPN : 41.05 (-0.36%)
MRK : 63.22 (-0.19%)
ZTS : 65.81 (+0.15%)
AKRX : 33.25 (+0.12%)
Depomed Inc has the Best Relative Performance in the Pharmaceuticals Industry (DEPO, LCI, IPXL, SCMP, ZGNX)

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

LCI : 23.15 (-2.32%)
SCMP : 10.35 (+3.50%)
IPXL : 19.30 (-3.26%)
ZGNX : 38.10 (-1.17%)
DEPO : 5.25 (+3.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Sucampo Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones...

See More

Support & Resistance

2nd Resistance Point 10.81
1st Resistance Point 10.58
Last Price 10.35
1st Support Level 10.04
2nd Support Level 9.72

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart